RETRACTED: Efficacy of bisphosphonates against hip fracture in elderly patients with stroke and Parkinson diseases: meta-analysis of randomized controlled trials
- PMID: 25314942
- DOI: 10.1016/j.jstrokecerebrovasdis.2014.06.022
RETRACTED: Efficacy of bisphosphonates against hip fracture in elderly patients with stroke and Parkinson diseases: meta-analysis of randomized controlled trials
Retraction in
-
Retraction notice to "Efficacy of Bisphosphonates against Hip Fracture in Elderly Patients with Stroke and Parkinson Diseases: Meta-analysis of Randomized Controlled Trials" [Journal of Stroke and Cerebrovascular Diseases, Vol. 23, No. 10 (November-December), 2014: pp 2714-2724].J Stroke Cerebrovasc Dis. 2021 Apr;30(4):105682. doi: 10.1016/j.jstrokecerebrovasdis.2021.105682. J Stroke Cerebrovasc Dis. 2021. PMID: 33685623 No abstract available.
Abstract
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editor-in-Chief. This paper includes a meta-analysis based on papers by another author group that have since been retracted. Researchers can be misled by reading this paper, thus we have retracted it.
Keywords: Hip fracture; Parkinson’s disease; bisphosphonate; stroke.
Copyright © 2014 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
RETRACTED: Beneficial effect of etidronate therapy in chronically hospitalized, disabled patients with stroke.J Stroke Cerebrovasc Dis. 2010 May;19(3):198-203. doi: 10.1016/j.jstrokecerebrovasdis.2009.04.006. J Stroke Cerebrovasc Dis. 2010. Retraction in: J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2362. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.034. PMID: 20434046 Retracted. Clinical Trial.
-
RETRACTED: An open-label trial comparing alendronate and alphacalcidol in reducing falls and hip fractures in disabled stroke patients.J Stroke Cerebrovasc Dis. 2011 Jan-Feb;20(1):41-46. doi: 10.1016/j.jstrokecerebrovasdis.2009.10.007. Epub 2010 Jul 3. J Stroke Cerebrovasc Dis. 2011. Retraction in: J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104426. doi: 10.1016/j.jstrokecerebrovasdis.2019.104426. PMID: 20598577 Retracted. Clinical Trial.
-
Efficacy of oral bisphosphonates for preventing hip fracture in disabled patients with neurological diseases: a meta-analysis of randomized controlled trials among the Japanese population.Curr Med Res Opin. 2011 Jun;27(6):1141-8. doi: 10.1185/03007995.2011.570747. Epub 2011 Apr 1. Curr Med Res Opin. 2011. Retraction in: Curr Med Res Opin. 2017 Jun;33(6):1181. doi: 10.1080/03007995.2017.1299998. PMID: 21456887 Retracted.
-
Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials.Curr Med Res Opin. 2008 May;24(5):1379-84. doi: 10.1185/030079908x297321. Epub 2008 Apr 1. Curr Med Res Opin. 2008. Retraction in: Curr Med Res Opin. 2017 Jun;33(6):1179. doi: 10.1080/03007995.2017.1300004. PMID: 18384711 Retracted. Review.
-
Meta-analysis for the efficacy of bisphosphonates on hip fracture prevention.J Bone Miner Metab. 2020 Sep;38(5):678-686. doi: 10.1007/s00774-020-01096-z. Epub 2020 Mar 31. J Bone Miner Metab. 2020. PMID: 32236684 Review.
Cited by
-
An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature.BMJ Open. 2019 Oct 30;9(10):e031909. doi: 10.1136/bmjopen-2019-031909. BMJ Open. 2019. PMID: 31666272 Free PMC article.
-
A Comprehensive Fracture Prevention Strategy in Older Adults: The European Union Geriatric Medicine Society (EUGMS) Statement.J Nutr Health Aging. 2016;20(6):647-52. doi: 10.1007/s12603-016-0741-y. J Nutr Health Aging. 2016. PMID: 27273355 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical